PRO-DEX, INC. (PDEX) Operating Margin
- Operating margin · 12 months: Value 16.75%; Formula and calculation Operating income / revenue. Period ending 2026-06-30..
Operating margin
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Operating margin · 12 months | 16.75% | Operating income / revenue. Period ending 2026-06-30. $12.99M ÷ $77.55M × 100 ≈ 16.75% |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Operating income | 12.99M USD | Operating Income (Loss) |
| Revenue | 77.55M USD | |
| Cost of products and services | (m) | |
| Research and development | 3.35M USD | Research and Development Expense |
| Selling, general and administration | 8.00M USD | Selling, General and Administrative Expense |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Operating income (USD) | Revenue (USD) | Cost of products and services (USD) | Research and development (USD) | Selling, general and administration (USD) | Operating margin |
|---|---|---|---|---|---|---|
| 2026-06-30 | $12.99M | $77.55M | (m) | $3.35M | $8.00M | 16.75% |
| 2026-03-31 | $10.81M | $74.64M | (m) | $3.23M | (m) | 14.48% |
| 2025-12-31 | $11.35M | $72.10M | (m) | $3.35M | (m) | 15.74% |
| 2025-09-30 | $10.79M | $70.23M | (m) | $3.56M | (m) | 15.36% |
| 2025-06-30 | $10.69M | $66.59M | (m) | $3.64M | (m) | 16.05% |
| 2025-03-31 | $11.70M | $64.12M | (m) | $3.57M | (m) | 18.24% |
| 2024-12-31 | $10.27M | $61.00M | (m) | $3.38M | (m) | 16.83% |
| 2024-09-30 | $8.35M | $56.80M | (m) | $3.23M | (m) | 14.71% |
| 2024-06-30 | $7.17M | $53.84M | (m) | $3.19M | (m) | 13.32% |
| 2024-03-31 | $6.43M | $49.46M | (m) | $3.05M | (m) | 13.00% |
| 2023-12-31 | $6.29M | $48.24M | (m) | $3.00M | (m) | 13.03% |
| 2023-09-30 | $6.64M | $46.94M | (m) | $2.68M | (m) | 14.16% |
| 2023-06-30 | $5.76M | $46.09M | (m) | $2.80M | (m) | 12.50% |
| 2023-03-31 | $5.33M | $48.06M | (m) | $2.83M | (m) | 11.10% |
| 2022-12-31 | $4.29M | $44.25M | (m) | $2.78M | (m) | 9.69% |
| 2022-09-30 | $4.75M | $43.14M | (m) | $2.93M | (m) | 11.02% |
| 2022-06-30 | $5.12M | $42.04M | (m) | $2.98M | (m) | 12.19% |
| 2022-03-31 | $4.53M | $38.86M | (m) | $3.45M | (m) | 11.66% |
| 2021-12-31 | $5.38M | $41.34M | (m) | $3.90M | (m) | 13.00% |
| 2021-09-30 | $4.29M | $39.43M | (m) | $4.27M | (m) | 10.89% |
| 2021-06-30 | $4.53M | $38.03M | (m) | $4.38M | (m) | 11.90% |
| 2021-03-31 | $6.14M | $39.72M | (m) | $4.00M | (m) | 15.45% |
| 2020-12-31 | $5.98M | $36.49M | (m) | $3.51M | (m) | 16.38% |
| 2020-09-30 | $7.12M | $36.18M | (m) | $2.92M | (m) | 19.69% |
| 2020-06-30 | $7.07M | $34.83M | (m) | $2.31M | (m) | 20.28% |
| 2020-03-31 | $6.04M | $30.71M | (m) | $2.05M | (m) | 19.68% |
| 2019-12-31 | $5.24M | $29.06M | (m) | $2.03M | (m) | 18.02% |
| 2019-09-30 | $4.76M | $27.50M | (m) | $1.96M | (m) | 17.32% |
| 2019-06-30 | $5.00M | $27.17M | (m) | $1.88M | (m) | 18.39% |
| 2019-03-31 | $4.35M | $26.42M | (m) | $1.78M | (m) | 16.48% |
| 2018-12-31 | $4.09M | $25.06M | (m) | $1.74M | (m) | 16.31% |
| 2018-09-30 | $3.25M | $24.22M | (m) | $1.89M | (m) | 13.40% |
| 2018-06-30 | $2.39M | $22.46M | (m) | $1.89M | (m) | 10.65% |
| 2018-03-31 | $2.66M | $21.81M | (m) | $1.83M | (m) | 12.21% |
| 2017-12-31 | $3.38M | $22.94M | (m) | $1.53M | (m) | 14.74% |
| 2017-09-30 | $3.30M | $21.98M | (m) | $1.33M | (m) | 15.03% |
| 2017-06-30 | $2.73M | $21.94M | (m) | $1.23M | (m) | 12.46% |
| 2017-03-31 | $1.84M | $22.30M | (m) | $1.86M | (m) | 8.25% |
| 2016-12-31 | $667.00K | $20.86M | (m) | $1.91M | (m) | 3.20% |
| 2016-09-30 | $938.00K | $21.47M | (m) | $1.90M | (m) | 4.37% |
| 2016-06-30 | $526.00K | $20.16M | (m) | $1.85M | (m) | 2.61% |
| 2016-03-31 | $398.00K | $18.95M | (m) | $1.67M | (m) | 2.10% |
| 2015-12-31 | $-41.00K | $17.53M | (m) | $1.70M | (m) | -0.23% |
| 2015-09-30 | $-832.00K | $14.88M | (m) | $1.71M | (m) | -5.59% |
| 2015-06-30 | $-902.00K | $13.38M | (m) | $1.67M | (m) | -6.74% |
| 2015-03-31 | $-989.00K | $12.52M | (m) | $1.67M | (m) | -7.90% |
| 2014-12-31 | $-1.04M | $11.01M | (m) | $1.57M | (m) | -9.47% |
| 2014-09-30 | $-1.02M | $10.85M | (m) | $1.49M | (m) | -9.44% |
| 2014-06-30 | $-814.00K | $10.81M | (m) | $1.48M | (m) | -7.53% |
| 2014-03-31 | $-1.49M | (m) | (m) | $1.55M | (m) | (m) |
| 2013-12-31 | $-1.82M | (m) | (m) | $1.66M | (m) | (m) |
| 2013-09-30 | $-1.82M | (m) | (m) | $1.76M | (m) | (m) |
| 2013-06-30 | $-1.90M | (m) | (m) | $1.79M | (m) | (m) |
| 2013-03-31 | $-1.90M | $13.18M | (m) | $1.87M | (m) | -14.43% |
| 2012-12-31 | $-1.83M | $14.66M | (m) | $1.87M | (m) | -12.51% |
| 2012-09-30 | $-1.77M | $15.67M | (m) | $1.91M | (m) | -11.32% |
| 2012-06-30 | $-1.36M | $17.26M | (m) | $2.07M | (m) | -7.91% |
| 2012-03-31 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-12-31 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-06-30 | $3.48M | $24.06M | (m) | $1.89M | (m) | 14.46% |
| 2011-03-31 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-12-31 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| Profound Medical Corp. (PROF) | $0.206B | -7.37 | |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |